News

Volition Announces Groundbreaking Lateral Flow Test for Point-of-Care Quantification of Nucleosomes
VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces it has demonstrated quantification of nucleosomes in whole venous blood in minutes ...